174 related articles for article (PubMed ID: 17291233)
21. Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational study.
Stukan M; Badocha M; Ratajczak K
BMC Cancer; 2019 Jun; 19(1):564. PubMed ID: 31185938
[TBL] [Abstract][Full Text] [Related]
22. Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses.
Pereira PN; Sarian LO; Yoshida A; Araújo KG; Barros RHO; Baião AC; Parente DB; Derchain S
Diagn Interv Radiol; 2018; 24(2):63-71. PubMed ID: 29467113
[TBL] [Abstract][Full Text] [Related]
23. Adnexal masses: characterization and imaging strategies.
Griffin N; Grant LA; Sala E
Semin Ultrasound CT MR; 2010 Oct; 31(5):330-46. PubMed ID: 20974354
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses.
Ali N; Jan H; Van Trappen P; Nasreen F; Canizales A; Carroll MJ; Granowska M; Jacobs I; Britton KE
BJOG; 2003 May; 110(5):508-14. PubMed ID: 12742337
[TBL] [Abstract][Full Text] [Related]
25. Risk of malignancy index in preoperative evaluation of pelvic masses.
Ashrafgangooei T; Rezaeezadeh M
Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553
[TBL] [Abstract][Full Text] [Related]
26. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
Dora SK; Dandapat AB; Pande B; Hota JP
J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
[TBL] [Abstract][Full Text] [Related]
27. [The use of 2-dimensional and 3-dimensional color and power-Doppler in the diagnosis of blood flow indices of adnexal tumors].
Czekierdowski A; Stachowicz N; Smoleń A; Kotarski J
Ginekol Pol; 2006 Apr; 77(4):296-306. PubMed ID: 16875035
[TBL] [Abstract][Full Text] [Related]
28. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
[TBL] [Abstract][Full Text] [Related]
29. Comparison of three risk of malignancy indices in evaluation of pelvic masses.
Manjunath AP; Pratapkumar ; Sujatha K; Vani R
Gynecol Oncol; 2001 May; 81(2):225-9. PubMed ID: 11330953
[TBL] [Abstract][Full Text] [Related]
30. Correlation of pelvic magnetic resonance imaging diagnosis with pathology for indeterminate adnexal masses.
Haggerty AF; Hagemann AR; Chu C; Siegelman ES; Rubin SC
Int J Gynecol Cancer; 2014 Sep; 24(7):1215-21. PubMed ID: 25153677
[TBL] [Abstract][Full Text] [Related]
31. Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands.
Meys EM; Rutten IJ; Kruitwagen RF; Slangen BF; Bergmans MG; Mertens HJ; Nolting E; Boskamp D; Beets-Tan RG; van Gorp T
BMC Cancer; 2015 Jun; 15():482. PubMed ID: 26111920
[TBL] [Abstract][Full Text] [Related]
32. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
33. Predictive Value of Malignancy Risk Indices for Ovarian Masses in Premenopausal and Postmenopausal Women.
Ertas S; Vural F; Vural F; Tufekci EC; Ertas AC; Kose G; Aka N
Asian Pac J Cancer Prev; 2016; 17(4):2177-83. PubMed ID: 27221915
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Evaluation of the ADNEX Model for the Prediction of the Ovarian Cancer Risk of Adnexal Masses at Siriraj Hospital.
Poonyakanok V; Tanmahasamut P; Jaishuen A; Wongwananuruk T; Asumpinwong C; Panichyawat N; Chantrapanichkul P
Gynecol Obstet Invest; 2021; 86(1-2):132-138. PubMed ID: 33596584
[TBL] [Abstract][Full Text] [Related]
35. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.
Thomassin-Naggara I; Poncelet E; Jalaguier-Coudray A; Guerra A; Fournier LS; Stojanovic S; Millet I; Bharwani N; Juhan V; Cunha TM; Masselli G; Balleyguier C; Malhaire C; Perrot NF; Sadowski EA; Bazot M; Taourel P; Porcher R; Darai E; Reinhold C; Rockall AG
JAMA Netw Open; 2020 Jan; 3(1):e1919896. PubMed ID: 31977064
[TBL] [Abstract][Full Text] [Related]
36. Addition of parity to the risk of malignancy index score in evaluating adnexal masses.
Yavuzcan A; Çağlar M; Özgü E; Üstün Y; Dilbaz S; Ozdemir I; Güngör T; Kumru S
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):518-22. PubMed ID: 25510694
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of adnexal masses.
Rajkotia K; Veeramani M; Macura KJ
Top Magn Reson Imaging; 2006 Dec; 17(6):379-97. PubMed ID: 17417086
[TBL] [Abstract][Full Text] [Related]
38. MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology.
Bazot M; Nassar-Slaba J; Thomassin-Naggara I; Cortez A; Uzan S; Daraï E
Eur Radiol; 2006 Dec; 16(12):2687-99. PubMed ID: 16547708
[TBL] [Abstract][Full Text] [Related]
39. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.
Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881
[TBL] [Abstract][Full Text] [Related]
40. An improved risk of malignancy index in diagnosis of adnexal mass.
Wang LM; Song H; Song X; Zhou XB
Chin Med J (Engl); 2012 Feb; 125(3):533-5. PubMed ID: 22490416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
